DK0698216T4 - Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri - Google Patents

Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri

Info

Publication number
DK0698216T4
DK0698216T4 DK94916061T DK94916061T DK0698216T4 DK 0698216 T4 DK0698216 T4 DK 0698216T4 DK 94916061 T DK94916061 T DK 94916061T DK 94916061 T DK94916061 T DK 94916061T DK 0698216 T4 DK0698216 T4 DK 0698216T4
Authority
DK
Denmark
Prior art keywords
methods
virus
reagents used
type
typing
Prior art date
Application number
DK94916061T
Other languages
English (en)
Other versions
DK0698216T3 (da
Inventor
David Y Chien
George Kuo
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22029220&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0698216(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK0698216T3 publication Critical patent/DK0698216T3/da
Publication of DK0698216T4 publication Critical patent/DK0698216T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94916061T 1993-05-10 1994-05-09 Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri DK0698216T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6040093A 1993-05-10 1993-05-10
PCT/US1994/005151 WO1994027153A1 (en) 1993-05-10 1994-05-09 Methods of typing hepatitis c virus and reagents for use therein

Publications (2)

Publication Number Publication Date
DK0698216T3 DK0698216T3 (da) 2005-02-14
DK0698216T4 true DK0698216T4 (da) 2009-06-15

Family

ID=22029220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916061T DK0698216T4 (da) 1993-05-10 1994-05-09 Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri

Country Status (19)

Country Link
US (3) US6054264A (da)
EP (1) EP0698216B2 (da)
JP (1) JP3645904B2 (da)
KR (1) KR100330278B1 (da)
CN (1) CN1129795C (da)
AT (1) ATE281647T1 (da)
CZ (1) CZ294629B6 (da)
DE (1) DE69434117T3 (da)
DK (1) DK0698216T4 (da)
ES (1) ES2232815T5 (da)
GE (1) GEP20012421B (da)
HU (1) HU224513B1 (da)
PL (3) PL175360B1 (da)
PT (1) PT698216E (da)
RO (1) RO115471B1 (da)
RU (1) RU2158928C2 (da)
SK (1) SK282543B6 (da)
UA (1) UA46707C2 (da)
WO (1) WO1994027153A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671967B2 (en) * 1991-11-21 1996-09-19 Common Services Agency Hepatitis-C virus testing
WO1994025601A2 (en) 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
US7255997B1 (en) * 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
DK0698216T4 (da) * 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
AU2352995A (en) * 1995-04-28 1996-11-18 Srl Inc. Antigen peptide compound and immunoassay method
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
US8124348B2 (en) 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
CA2481502A1 (en) * 2002-04-04 2003-10-16 Achillion Pharmaceuticals, Inc. Hcv antiviral and cytotoxicity drug screening assay
WO2005010035A2 (en) * 2003-07-22 2005-02-03 Branch Andrea D Alternate reading frame polypeptides derived from hepatitis c and methods of their use
WO2005009418A2 (en) * 2003-07-25 2005-02-03 Idenix (Cayman) Limited Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
US8124747B2 (en) * 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
US7473773B2 (en) * 2004-01-07 2009-01-06 Third Wave Technologies, Inc. Determination of hepatitis C virus genotype
JP4533656B2 (ja) * 2004-04-28 2010-09-01 アボットジャパン株式会社 特異性の改良されたｃ型肝炎ウイルス（ｈｃｖ）抗体測定法
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
IE62868B1 (en) * 1987-11-18 1995-03-08 Chiron Corp Hepatitis C virus
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
UA50829C2 (uk) * 1989-03-17 2002-11-15 Чірон Корпорейшн Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US6190864B1 (en) * 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
HU227547B1 (en) * 1991-06-24 2011-08-29 Novartis Vaccines & Diagnostic Hepatitis c virus (hcv) polypeptides
ES2198514T3 (es) * 1991-08-27 2004-02-01 F. Hoffmann-La Roche Ag Cebadores y sondas para la deteccion de la hepatitis c.
US5427909A (en) * 1991-09-09 1995-06-27 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
ATE191792T1 (de) * 1991-09-16 2000-04-15 Abbott Lab Verfahren zur detektion von hepatitis c
AU671967B2 (en) * 1991-11-21 1996-09-19 Common Services Agency Hepatitis-C virus testing
EP1878797B1 (en) 1992-07-16 2010-04-28 Advanced Life Science Institute, Inc Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
EP0672049A4 (en) * 1992-11-06 1997-10-15 Chiron Mimotopes Pty Ltd SUPPORT FOR THE SYNTHESIS OF MODULE POLYMERS.
AU695259B2 (en) 1993-05-05 1998-08-13 Common Services Agency Hepatitis-C virus type 4, 5 and 6
DK0698216T4 (da) * 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
US5885771A (en) * 1993-10-29 1999-03-23 Srl, Inc. Antigenic peptide compound and immunoassay

Also Published As

Publication number Publication date
PL175338B1 (pl) 1998-12-31
CZ292995A3 (en) 1996-05-15
US6054264A (en) 2000-04-25
CN1129795C (zh) 2003-12-03
DE69434117T3 (de) 2009-10-08
US6416944B1 (en) 2002-07-09
WO1994027153A1 (en) 1994-11-24
PL175342B1 (pl) 1998-12-31
CN1125982A (zh) 1996-07-03
PT698216E (pt) 2005-03-31
EP0698216B1 (en) 2004-11-03
US6416946B1 (en) 2002-07-09
EP0698216A1 (en) 1996-02-28
PL175360B1 (pl) 1998-12-31
PL311653A1 (en) 1996-03-04
HU224513B1 (hu) 2005-10-28
EP0698216B2 (en) 2009-02-25
RU2158928C2 (ru) 2000-11-10
HUT73384A (en) 1996-07-29
JPH08510329A (ja) 1996-10-29
GEP20012421B (en) 2001-04-25
SK282543B6 (sk) 2002-10-08
DE69434117D1 (de) 2005-01-20
RO115471B1 (ro) 2000-02-28
CZ294629B6 (cs) 2005-02-16
HU9503219D0 (en) 1996-01-29
JP3645904B2 (ja) 2005-05-11
SK135995A3 (en) 1996-09-04
DE69434117T2 (de) 2006-02-02
ATE281647T1 (de) 2004-11-15
KR100330278B1 (ko) 2002-08-19
UA46707C2 (uk) 2002-06-17
ES2232815T3 (es) 2005-06-01
DK0698216T3 (da) 2005-02-14
ES2232815T5 (es) 2009-06-15

Similar Documents

Publication Publication Date Title
DK0698216T4 (da) Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
ID21649A (id) Inhibitor serum protease, terutama virus hepatitis c ns3 protease
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
DE68927025T2 (de) HIV-2-Virusvarianten
DE69232906T2 (de) Detektion des Hepatis-C Virus.
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DK0489968T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DK149589D0 (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
ATE162553T1 (de) Monoklonale antikörper gegen hepatitis-c-virus
DK1002092T3 (da) Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf
WO1998037180A3 (en) Hcv fusion protease and polynucleotide encoding same
DK112797A (da) Lufthavn og drift af denne.
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
ATE115964T1 (de) Non-a non-b sequenzen.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
FI943929A (fi) Hepatiitti C-viruspeptidejä
EP0593291A3 (en) Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
IT1270941B (it) Peptidi di hcv e loro usi.
DE69824881D1 (de) Kompakte replikons des epstein-barr-virus.
DK0488812T3 (da) Non-A, non-B hepatitis-relaterede nucleinsyrer, antigener og antistoffer samt reagenser til deres påvisning